REFRACTORY METASTATIC COLORECTAL CANCER
Clinical trials for REFRACTORY METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for REFRACTORY METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough colorectal cancer: drug combo trial launches
Disease control Recruiting nowThis study tests whether adding the experimental drug suvemcitug to standard chemotherapy (FTD/TPI) helps people with advanced colorectal cancer that no longer responds to other treatments live longer. About 464 participants will receive either suvemcitug plus chemotherapy or a p…
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:40 UTC
-
New combo targets liver tumors in hard-to-treat colorectal cancer
Disease control Recruiting nowThis study tests whether giving a strong chemotherapy directly to the liver, followed by standard cancer drugs, works better than the standard drugs alone for people with colorectal cancer that has spread mainly to the liver and is no longer responding to other treatments. About …
Matched conditions: REFRACTORY METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Delcath Systems Inc. • Aim: Disease control
Last updated May 26, 2026 11:36 UTC